Clearmind Medicine Completes Participant Recruitment For First Segment Of Part B Of Its Phase I/IIa Clinical Study Of CMND-100 To Treat Alcohol Use Disorder

뉴스 본문을 불러오고 있어요.

Clearmind Medicine Completes Participant Recruitment For First Segment Of Part B Of Its Phase I/IIa Clinical Study Of CMND-100 To Treat Alcohol Use Disorder | 웨이프 WAPE

Clearmind Medicine Completes Participant Recruitment For First Segment Of Part B Of Its Phase I/IIa Clinical Study Of CMND-100 To Treat Alcohol Use Disorder

기사 요약

관련 종목

웨이프 AI가 분석했어요.

Clearmind Medicine이 CMND-100 임상 시험의 환자 모집을 완료함

댓글 —